Supply Chain Intelligence

Lipella Pharmaceuticals Inc. Supply Chain

LIPO supply chain intelligence for Lipella Pharmaceuticals Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

LIPO ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
3Customers
2Debt Items
20Related Chains

Lipella Pharmaceuticals Inc. Suppliers

TickerNameConfidenceEvidence
ORANY ORANY 72% Chemistry, Manufacturing and Controls (“CMC”) section of the IND application prior to and in conjunction with use in any subsequent clinical trial. Our Analytical Laboratory, Equipment & Supplies Our…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from LIPO graph: Chemistry, Manufacturing and Controls (“CMC”) section of the IND application prior to and in conjunction with use in…

Lipella Pharmaceuticals Inc. Customers

TickerNameConfidenceEvidence
BRIDGEWAY-DEVELOPMENT-CORPORATION BRIDGEWAY-DEVELOPMENT-CORPORATION 85% ), commencing August 1, 2023 and co-terminating with the existing Lease on June 30, 2025. Subsequently effective January 1, 2024, the Company terminated the Fourth Floor Lease early at no penalty upo…
ORANY ORANY 72% Item 13. Certain Relationships and Related Transactions, and Director Independence 83 Item 14. Principal Accountant Fees and Services 84 PART IV 86 Item 15. Exhibits and Financial Statement Schedules…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from LIPO graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from LIPO graph: Reciprocal relationship from ORAN…

Lipella Pharmaceuticals Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LIPO-DEBT Debt stack $264,083 90% Market cache reports total debt of $264,083.
LIPO-DEBT-10718 Warrants outstanding: 117750 90% xbrl warrant detail from xbrl 2025-09-30.

Lipella Pharmaceuticals Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Lipella Pharmaceuticals Inc..

Lipella Pharmaceuticals Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Lipella Pharmaceuticals Inc..

Lipella Pharmaceuticals Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
SCNX Scienture Holdings, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
BLTE Belite Bio, Inc 50.00 2
View LIPO supply chain intel →

Explore the full interactive supply chain map for Lipella Pharmaceuticals Inc..

Open LIPO supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map